Rodney W Lappe - Net Worth and Insider Trading
Rodney W Lappe Net Worth
The estimated net worth of Rodney W Lappe is at least $831,400 dollars as of 2024-12-29. Rodney W Lappe is the Director of Design Therapeutics Inc and owns about 133,024 shares of Design Therapeutics Inc (DSGN) stock worth over $831,400. Details can be seen in Rodney W Lappe's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Rodney W Lappe has not made any transactions after 2023-09-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Rodney W Lappe
Rodney W Lappe Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Rodney W Lappe owns 2 companies in total, including Mirati Therapeutics Inc (MRTX) , and Design Therapeutics Inc (DSGN) .
Click here to see the complete history of Rodney W Lappe’s form 4 insider trades.
Insider Ownership Summary of Rodney W Lappe
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MRTX | Mirati Therapeutics Inc | 2017-01-06 | 10 percent owner |
| DSGN | Design Therapeutics Inc | 2023-09-29 | director |
Rodney W Lappe Latest Holdings Summary
Rodney W Lappe currently owns a total of 1 stock. Rodney W Lappe owns 133,024 shares of Design Therapeutics Inc (DSGN) as of September 29, 2023, with a value of $831,400.
Latest Holdings of Rodney W Lappe
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DSGN | Design Therapeutics Inc | 2023-09-29 | 133,024 | 6.25 | 831,400 |
Holding Weightings of Rodney W Lappe
Rodney W Lappe Form 4 Trading Tracker
According to the SEC Form 4 filings, Rodney W Lappe has made a total of 3 transactions in Design Therapeutics Inc (DSGN) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Design Therapeutics Inc is the acquisition of 21,000 shares on September 29, 2023, which cost Rodney W Lappe around $49,350.
Insider Trading History of Rodney W Lappe
- 1
Rodney W Lappe Trading Performance
GuruFocus tracks the stock performance after each of Rodney W Lappe's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Rodney W Lappe is -11.65%. GuruFocus also compares Rodney W Lappe's trading performance to market benchmark return within the same time period. The performance of stocks bought by Rodney W Lappe within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Rodney W Lappe's insider trading performs compared to the benchmark.
Performance of Rodney W Lappe
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -3.51 | | | | | |
| Relative Return to S&P 500(%) | -3.7 | | | | | |
Rodney W Lappe Ownership Network
Rodney W Lappe Owned Company Details
What does Mirati Therapeutics Inc do?
Who are the key executives at Mirati Therapeutics Inc?
Rodney W Lappe is the 10 percent owner of Mirati Therapeutics Inc. Other key executives at Mirati Therapeutics Inc include Sr. Vice President & Chief Scie Jamie Christensen , EVP & Chief Commercial Officer Benjamin Hickey , and Interim CFO Aaron Ondrey .
Mirati Therapeutics Inc (MRTX) Insider Trades Summary
Over the past 18 months, Rodney W Lappe made no insider transaction in Mirati Therapeutics Inc (MRTX). Other recent insider transactions involving Mirati Therapeutics Inc (MRTX) include a net sale of 7,903 shares made by Jamie Christensen , a net sale of 5,907 shares made by Benjamin Hickey , and a net purchase of 2,517,946 shares made by Boxer Capital, Llc .
In summary, during the past 3 months, insiders sold 0 shares of Mirati Therapeutics Inc (MRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 13,810 shares of Mirati Therapeutics Inc (MRTX) were sold and 2,528,737 shares were bought by its insiders, resulting in a net purchase of 2,514,927 shares.
Mirati Therapeutics Inc (MRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Mirati Therapeutics Inc Insider Transactions
Rodney W Lappe Mailing Address
Above is the net worth, insider trading, and ownership report for Rodney W Lappe. You might contact Rodney W Lappe via mailing address: C/o Mirati Therapeutics Inc., 4660 La Jolla Village Drive, Suite 500, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
